|
Company was informed of a revision procedure of 2 staples.An investigation was performed including internal analysis of records.No imaging was provided.No information on clinical symptoms was shared.Revision surgery was performed successfully.Fragments of the removed implants were returned to the company and examined.There is no indication of a design, manufacturing or process issue affecting implant safety, effectiveness or sterility.Based on the limited information available the root cause leading to revision surgery could not be determined.Several known inherent risks, both procedure and patient related may lead to additional surgeries and device removals.As a revision surgery was performed and because the company cannot rule out the possible contribution of the device to the event, out of an abundance of caution, this event is being reported.Company continues to monitor these events as part of post market activities.Additional reports relating to this event are: # 3014323288-2026-00008 and 3014554088-2026-00008/9.
|